Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > Why HIP at 2.20 someone may ask...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by MartialArtson Jan 22, 2018 5:41pm
115 Views
Post# 27411270

RE:RE:RE:Why HIP at 2.20 someone may ask...

RE:RE:RE:Why HIP at 2.20 someone may ask...
There is no new deal to be accepted.  It's a done deal at 33 CMED shares for each 1000 HIP shares.  HIP shareholders overwhelmingly approved it.

The ball is in CMED's court.  They can continue to recommend it to CMED holders or, they can decide to bail and pay the separation fee.

HIP already has signed an 18 months supply deal starting this month with CMED. Either way CMED covered its bases.

Now, it's negociating with ACB.   ACB needs CMED for its dominance play.  CMED does not need ABC for its recreational play.  In fact, some shareholders would prefer to run the UP Cannabis brand with HIP.

Either way, it was easy to add more CMED today.  Sold part, rebought it on the trade and added a lot more during the day.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities